top of page
Biotech Stories, News & Events

Similar Stories from FIB

Made by Cells - Biotech Forum - April 10th 2025
24/02/25
Made by Cells - Biotech Forum - April 10th 2025
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline
04/02/25
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and technology alliance to boost capacity for Eleva’s platform and pipeline
Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A 
13/01/25
Rappta Therapeutics enters into a global license agreement with SpringWorks Therapeutics for a pre-clinical first-in-class molecular glue targeting PP2A 
Sartar Therapeutics: A New Precision Therapy for Rare Soft Tissue Cancers
14/12/24
Sartar Therapeutics: A New Precision Therapy for Rare Soft Tissue Cancers

Finnish Bioindustries warmly welcomes Synbio Powerlabs as its newest member!

Synbio Powerlabs is currently building a state-of-the-art pilot facility in Lappeenranta, Finland. Upon completion, this facility will feature aseptic, food-grade bioreactors ranging from 50 liters to 2 x 27,000 liters, with intermediate capacities of 500 liters and 10,000 liters. This infrastructure will provide crucial opportunities for companies worldwide to scale up their groundbreaking biotech innovations.


Their recent collaboration with Ivy Farm, a British company, exemplifies their commitment to pushing the boundaries of biomanufacturing. This partnership aims to scale up cultivated meat production to a significant 10,000 liters.


For more information about Synbio Powerlabs, please visit their website at www.synbiopowerlabs.com.




bottom of page